$7.72 0.18 (+2.39%)
11/24/2009 4:00 PM

Incyte Corp (INCY)

CAPS Rating: 3 out of 5

The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.

Featured Broker Partners